None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female at least 19 years old 2. Patients scheduled for intrauterine surgery because of the following gynecological diseases - Submucosal myoma - Endometrial polyp - Uterine septa - Endometrial hyperplasia - Intrauterine adhesion - Abnormal uterine bleeding 3. Patients who are willing to voluntarily participate in the trial and are willing to follow the protocol
Exclusion criteria
Exclusion criteria: If any of the following criteria are met, a target subject can not be enrolled. ? Pregnant, lactating women, and women having a pregnancy plan during the clinical trial ? Patients who intend to use an intrauterine device for contraception during the clinical trial ? Patients who need hormone therapy after intrauterine surgery ? Patients who had GnRH hormone therapy within 3 months before screening ? Patients who have local or systemic infection, endometrial cancer (uterus and endometrium, cervical cancer) and excessive uterine bleeding ? Patients who have abnormal liver function, abnormal kidney function, abnormal hemostatic function ? Patients who are applied anti-coagulants or who took systemic steroids within 1 week before surgical operation ? Patients with immunosuppression or autoimmune diseases ? Patients with uncontrolled diabetes ? Patients with hypersensitivity to the medical device for clinical trials ? Patients who have participated in other clinical trials within 30 days prior to participating in this clinical trial ? In the case that investigators made a decision that a person is inappropriate to participate in the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the adhesion incidence rate;All adverse events that occurred to the subjects | — |
Secondary
| Measure | Time frame |
|---|---|
| the mean score of adhesion type;the mean score of adhesion extent | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital